Cooper Cos. Downgraded to “Sell” at Citigroup Inc. (COO)
Cooper Cos. (NYSE:COO) was downgraded by equities researchers at Citigroup Inc. from a “neutral” rating to a “sell” rating in a research report issued on Tuesday, TheFlyOnTheWall.com reports. They currently have a $116.00 price target on the stock, down from their previous price target of $128.00. Citigroup Inc.’s price objective would indicate a potential downside of 6.41% from the company’s current price.
Separately, analysts at Zacks reiterated a “neutral” rating on shares of Cooper Cos. in a research note to investors on Thursday, November 28th. They now have a $138.00 price target on the stock. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company. Cooper Cos. presently has a consensus rating of “Buy” and a consensus target price of $131.57.
Cooper Cos. (NYSE:COO) traded up 1.37% during mid-day trading on Tuesday, hitting $123.95. 785,352 shares of the company’s stock traded hands. Cooper Cos. has a 1-year low of $96.04 and a 1-year high of $135.41. The stock has a 50-day moving average of $126.5 and a 200-day moving average of $127.7. The company has a market cap of $5.950 billion and a price-to-earnings ratio of 20.52.
Cooper Cos. (NYSE:COO) last announced its earnings results on Thursday, December 5th. The company reported $1.48 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.80 by $0.32. The company had revenue of $411.90 million for the quarter, compared to the consensus estimate of $421.58 million. During the same quarter in the previous year, the company posted $1.47 earnings per share. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. Analysts expect that Cooper Cos. will post $6.82 EPS for the current fiscal year.
In other Cooper Cos. news, Director Steven Rosenberg sold 17,500 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $122.56, for a total value of $2,144,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
The Cooper Companies, Inc (NYSE:COO) is a global medical products company that serves the specialty healthcare market through its two business units, CooperVision, Inc (CVI) and CooperSurgical, Inc (CSI).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.